GlaxoSmithKline signs multi-part deal with rival Novartis 22-04-14 10:12 AM GlaxoSmithKline has agreed to sell its oncology portfolio to Novartis, while Novartis will sell its vaccines business for an initial $5.25billion (£3.1billion) to Glaxo. Source... |
الساعة الآن 01:12 PM |
Powered by vBulletin® Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Content Relevant URLs by vBSEO 3.5.2 TranZ By
Almuhajir